First Horizon Advisors’s Kyntra Bio KYNB Stock Holding History

First Horizon Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14	Closed	-$12K	–	2009
2021 Q1	$12K	Hold	14	–	–	﹤0.01%	1231
2020 Q4	$13K	Sell	14 -13	-48%	-$13.7K	﹤0.01%	1002
2020 Q3	$28K	Buy	27 +7	+35%	+$7.53K	﹤0.01%	707
2020 Q2	$20K	Hold	20	–	–	﹤0.01%	802
2020 Q1	$17K	Hold	20	–	–	﹤0.01%	793
2019 Q4	$21K	Hold	20	–	–	﹤0.01%	841
2019 Q3	$18K	Hold	20	–	–	﹤0.01%	879
2019 Q2	$22K	Sell	20 -1	-5%	-$1.09K	﹤0.01%	839
2019 Q1	$27K	Buy	+21	New	+$28.5K	﹤0.01%	712

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Horizon Advisors's KYNB Position: Q2 2021 in Review

First Horizon Advisors sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 14 shares — an estimated $12K sold.

First Horizon Advisors first reported a position in KYNB in Q1 2019 and held it in 9 quarters. The position peaked at $28K in Q3 2020. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

First Horizon Advisors reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
First Horizon Advisors sold 14 Kyntra Bio shares in Q2 2021, an estimated $12K.
First Horizon Advisors first reported a position in Kyntra Bio in Q1 2019 and held it in 9 quarters.
First Horizon Advisors's Kyntra Bio position peaked at $28K in Q3 2020.
174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on First Horizon Advisors's 13F filing for Q2 2021, filed 9 Aug 2021.